OptiNose Inc. held a special meeting of stockholders on May 16, 2025. During the meeting, stockholders voted on a proposal to adopt the Agreement and Plan of Merger with Paratek Pharmaceuticals, Inc. and Orca Merger Sub, Inc. This proposal was approved. Additionally, a proposal to approve adjournments of the Special Meeting, if necessary, was deemed unnecessary and was not submitted for approval.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OptiNose Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-049925), on May 16, 2025, and is solely responsible for the information contained therein.